Cargando…
Mesenchymal Stromal Cells Are More Effective Than Their Extracellular Vesicles at Reducing Lung Injury Regardless of Acute Respiratory Distress Syndrome Etiology
Although mesenchymal stromal cells (MSCs) have demonstrated beneficial effects on experimental acute respiratory distress syndrome (ARDS), preconditioning may be required to potentiate their therapeutic effects. Additionally, administration of cell-free products, such as extracellular vesicles (EVs)...
Autores principales: | Silva, Johnatas D., de Castro, Ligia L., Braga, Cassia L., Oliveira, Gisele P., Trivelin, Stefano A., Barbosa-Junior, Carlos M., Morales, Marcelo M., dos Santos, Claudia C., Weiss, Daniel J., Lopes-Pacheco, Miquéias, Cruz, Fernanda F., Rocco, Patricia R. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6720722/ https://www.ncbi.nlm.nih.gov/pubmed/31531026 http://dx.doi.org/10.1155/2019/8262849 |
Ejemplares similares
-
Eicosapentaenoic acid potentiates the therapeutic effects of adipose tissue-derived mesenchymal stromal cells on lung and distal organ injury in experimental sepsis
por: Silva, Johnatas D., et al.
Publicado: (2019) -
Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Lung Diseases: Current Status and Perspectives
por: Abreu, Soraia C., et al.
Publicado: (2021) -
Mesenchymal Stromal Cells From Emphysematous Donors and Their Extracellular Vesicles Are Unable to Reverse Cardiorespiratory Dysfunction in Experimental Severe Emphysema
por: Antunes, Mariana A., et al.
Publicado: (2021) -
Functional enhancement strategies to potentiate the therapeutic properties of mesenchymal stromal cells for respiratory diseases
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2023) -
High Mortality of HLH in ICU Regardless Etiology or Treatment
por: Bichon, Amandine, et al.
Publicado: (2021)